Barr settles antitrust lawsuit over Ovcon for $5.9M

Generic-drug maker Barr Pharmaceuticals will pay $5.9 million to end an antitrust lawsuit filed by 34 states over claims that it received $20 million to hold off on marketing its version of Warner Chilcott Ltd.'s Ovcon, an oral contraceptive. Under the terms of the settlement, Barr is prohibited from entering into noncompetition agreements with firms that market brand name treatments for the next decade. A spokeswoman for Barr denied any wrongdoing, saying that the company still deems the deal with Warner Chilcott "legal, legitimate and pro-competitive."

View Full Article in:

California Chronicle (Los Angeles) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX